Julphar is a true reflection of Ras Al Khaimah’s significant development. Established in 1980 under the guidance of H.H Sheikh Saqr Bin Mohammed Al Qasimi, we have established ourselves as a leader in production and distribution of pharmaceutical products. Our goal is to create high quality medicines whilst maintaining a competitive cost. We achieve this through a network of twelve world-class manufacturing plants (with further expansion planned) and a reliable logistics network which covers five continents. We maintain a diverse product portfolio which target major therapeutic segments including endocrinology, anti-infective, cardiovascular and gastroenterology, over-the counter, nephrology, dermatology, respiratory, metabolic and burn and wound management. Highlighting our commitment to diabetes management in the region, we have also become the only company in the Middle East to produce the raw material needed to make insulin through our division dedicated to Diabetes. With over 800 products in various dosage forms and more in the pipeline, Julphar is an example of one of the UAE’s local businesses making an impact on the global stage.